{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:43:25Z","timestamp":1790621005254,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004702","name":"Baxter International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004702","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.clnu.2021.02.011","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T02:55:36Z","timestamp":1613357736000},"page":"4065-4074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Candidacy of adult patients with short bowel syndrome for treatment with glucagon-like peptide-2 analogues: A systematic analysis of a single centre cohort"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1773-8330","authenticated-orcid":false,"given":"Loris","family":"Pironi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9981-0086","authenticated-orcid":false,"given":"Anna Simona","family":"Sasdelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4993-1052","authenticated-orcid":false,"given":"Francesca Maria","family":"Venerito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8598-6101","authenticated-orcid":false,"given":"Alessandra","family":"Musio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Pazzeschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariacristina","family":"Guidetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clnu.2021.02.011_bib1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bpg.2016.02.011","article-title":"Definitions of intestinal failure and the short bowel syndrome","volume":"30","author":"Pironi","year":"2016","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.clnu.2021.02.011_bib2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/gut.46.5.701","article-title":"Intestinal failure defined by measurements of intestinal energy and wet weight absorption","volume":"46","author":"Jeppesen","year":"2000","journal-title":"Gut"},{"issue":"Suppl 4","key":"10.1016\/j.clnu.2021.02.011_bib3","first-page":"iv1","article-title":"Small bowel and nutrition committee of the British society of gastroenterology. Guidelines for management of patients with a short bowel","volume":"55","author":"Nightingale","year":"2006","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.clnu.2021.02.011_bib4","first-page":"171","article-title":"ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults","volume":"34","author":"Pironi","year":"2015","journal-title":"Clin Nutr Edinb Scotl"},{"issue":"2","key":"10.1016\/j.clnu.2021.02.011_bib5","first-page":"728","article-title":"Clinical classification of adult patients with chronic intestinal failure due to benign disease: an international multicenter cross-sectional survey","volume":"37","author":"Pironi","year":"2018","journal-title":"Clin Nutr Edinb Scotl"},{"issue":"1","key":"10.1016\/j.clnu.2021.02.011_bib6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/ajt.12979","article-title":"Intestinal transplant registry report: global activity and trends","volume":"15","author":"Grant","year":"2015","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"issue":"2","key":"10.1016\/j.clnu.2021.02.011_bib7","first-page":"247","article-title":"ESPEN guidelines on chronic intestinal failure in adults","volume":"35","author":"Pironi","year":"2016","journal-title":"Clin Nutr Edinb Scotl"},{"issue":"5","key":"10.1016\/j.clnu.2021.02.011_bib8","first-page":"493","article-title":"Short bowel syndrome: clinical guidelines for nutrition management","volume":"20","author":"Matarese","year":"2005","journal-title":"Nutr Clin Pract Off Publ Am Soc Parenter Enter Nutr"},{"issue":"6","key":"10.1016\/j.clnu.2021.02.011_bib9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archsurg.2010.103","article-title":"Intestinal failure management at the cleveland clinic","volume":"145","author":"Shatnawei","year":"2010","journal-title":"Arch Surg Chic Ill"},{"issue":"8","key":"10.1016\/j.clnu.2021.02.011_bib10","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1177\/0148607115582063","article-title":"Teduglutide for safe reduction of parenteral nutrient and\/or fluid requirements in adults: a systematic review","volume":"40","author":"Naberhuis","year":"2016","journal-title":"JPEN - J Parenter Enter Nutr"},{"issue":"9","key":"10.1016\/j.clnu.2021.02.011_bib11","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/gut.2004.061440","article-title":"Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients","volume":"54","author":"Jeppesen","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.clnu.2021.02.011_bib12","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1038\/ctg.2015.69","article-title":"Long-term teduglutide for the treatment of patients with intestinal failure associated with short bowel syndrome","volume":"7","author":"Schwartz","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"issue":"6","key":"10.1016\/j.clnu.2021.02.011_bib13","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/jpen.1757","article-title":"Translation of evidence into practice with teduglutide in the management of adults with intestinal failure due to short-bowel syndrome: a review of recent literature","volume":"44","author":"Pironi","year":"2020","journal-title":"JPEN - J Parenter Enter Nutr"},{"issue":"5","key":"10.1016\/j.clnu.2021.02.011_bib14","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41430-018-0278-8","article-title":"Examining the pathophysiology of short bowel syndrome and glucagon-like peptide 2 analogue suitability in chronic intestinal failure: experience from a national intestinal failure unit","volume":"73","author":"Bond","year":"2019","journal-title":"Eur J Clin Nutr"},{"issue":"8","key":"10.1016\/j.clnu.2021.02.011_bib15","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1586\/17474124.2013.842894","article-title":"Study of teduglutide effectiveness in parenteral nutrition-dependent short-bowel syndrome subjects","volume":"7","author":"Vipperla","year":"2013","journal-title":"Expet Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.clnu.2021.02.011_bib16","first-page":"520","article-title":"Reduction of parenteral nutrition and hydration support and safety with long-term teduglutide treatment in patients with short bowel syndrome-associated intestinal failure: STEPS-3 study","volume":"33","author":"Seidner","year":"2018","journal-title":"Nutr Clin Pract Off Publ Am Soc Parenter Enter Nutr"},{"key":"10.1016\/j.clnu.2021.02.011_bib17","series-title":"Reverstive (teduglutide). Full prescribing information. Dublin, Ireland","year":"2019"},{"key":"10.1016\/j.clnu.2021.02.011_bib18","series-title":"Full prescribing information","year":"2019"},{"issue":"5","key":"10.1016\/j.clnu.2021.02.011_bib19","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/TP.0000000000003065","article-title":"New insights into the indications for intestinal transplantation: consensus in the year 2019","volume":"104","author":"Kaufman","year":"2020","journal-title":"Transplantation"},{"issue":"7799","key":"10.1016\/j.clnu.2021.02.011_bib20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0140-6736(73)90131-1","article-title":"Role of the colon in ileal-resection diarrh\u0153a","volume":"301","author":"Cummings","year":"1973","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.clnu.2021.02.011_bib21","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1136\/gutjnl-2018-318172","article-title":"Intravenous supplementation type and volume are associated with 1-year outcome and major complications in patients with chronic intestinal failure","volume":"69","author":"Pironi","year":"2020","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.clnu.2021.02.011_bib22","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1053\/j.gastro.2012.09.007","article-title":"Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure","volume":"143","author":"Jeppesen","year":"2012","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.clnu.2021.02.011_bib23","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.clnu.2021.02.011_bib24","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1177\/0148607115612040","article-title":"Single-center, adult chronic intestinal failure cohort analyzed according to the ESPEN-endorsed recommendations, definitions, and classifications","volume":"41","author":"Brandt","year":"2017","journal-title":"JPEN - J Parenter Enter Nutr"},{"issue":"3","key":"10.1016\/j.clnu.2021.02.011_bib25","first-page":"368","article-title":"Determinants of home parenteral nutrition dependence and survival of 268 patients with non-malignant short bowel syndrome","volume":"32","author":"Amiot","year":"2013","journal-title":"Clin Nutr Edinb Scotl"},{"issue":"9","key":"10.1016\/j.clnu.2021.02.011_bib26","first-page":"2856","article-title":"Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: a real-world French observational cohort study","volume":"39","author":"Joly","year":"2020","journal-title":"Clin Nutr Edinb Scotl"},{"issue":"4","key":"10.1016\/j.clnu.2021.02.011_bib27","first-page":"1745","article-title":"Experience with teduglutide treatment for short bowel syndrome in clinical practice","volume":"38","author":"Pevny","year":"2019","journal-title":"Clin Nutr Edinb Scotl"},{"issue":"8","key":"10.1016\/j.clnu.2021.02.011_bib28","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1210\/jc.2018-00655","article-title":"The intestinotrophic effects of glucagon-like peptide-2 in relation to intestinal neoplasia","volume":"103","author":"Orhan","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1\u20132","key":"10.1016\/j.clnu.2021.02.011_bib29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mce.2012.08.008","article-title":"GLP-2 receptors in human disease: high expression in gastrointestinal stromal tumors and Crohn's disease","volume":"364","author":"K\u00f6rner","year":"2012","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"10.1016\/j.clnu.2021.02.011_bib30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/17474124.2018.1417032","article-title":"Glucagon like peptide-2 and neoplasia; a systematic review","volume":"12","author":"Ring","year":"2018","journal-title":"Expet Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.clnu.2021.02.011_bib31","first-page":"1774","article-title":"Colon polyps in patients with short bowel syndrome before and after teduglutide: post hoc analysis of the STEPS study series","volume":"39","author":"Armstrong","year":"2020","journal-title":"Clin Nutr Edinb Scotl"},{"key":"10.1016\/j.clnu.2021.02.011_bib32","doi-asserted-by":"crossref","DOI":"10.1177\/1756284820905766","article-title":"Teduglutide for the treatment of adults with intestinal failure associated with short bowel syndrome: pooled safety data from four clinical trials","volume":"13","author":"Pape","year":"2020","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.clnu.2021.02.011_bib33","article-title":"De novo development of distal jejunal and duodenal adenomas after 41 Months of teduglutide treatment in a patient with short-bowel syndrome: a case report","author":"Pevny","year":"2020","journal-title":"JPEN - J Parenter Enter Nutr"},{"issue":"3","key":"10.1016\/j.clnu.2021.02.011_bib34","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1177\/0148607117718480","article-title":"De novo development of hamartomatous duodenal polyps in a patient with short bowel syndrome during teduglutide therapy: a case report","volume":"42","author":"Ukleja","year":"2018","journal-title":"JPEN - J Parenter Enter Nutr"},{"issue":"3","key":"10.1016\/j.clnu.2021.02.011_bib35","first-page":"e275","article-title":"Accelerated colorectal polyposis in an immunosuppressed patient with a small bowel transplant treated with teduglutide: case report and review of literature","volume":"18","author":"George","year":"2019","journal-title":"Clin Colorectal Canc"},{"key":"10.1016\/j.clnu.2021.02.011_bib36","article-title":"Teduglutide therapy in 2 patients with short-bowel syndrome and familial adenomatous polyposis","author":"George","year":"2020","journal-title":"JPEN - J Parenter Enter Nutr"},{"key":"10.1016\/j.clnu.2021.02.011_bib37","first-page":"107479","article-title":"Alveolar rhabdomyosarcoma in a 69-year-old woman receiving glucagon-like peptide-2 therapy","volume":"2015","author":"Zyczynski","year":"2015","journal-title":"Case Rep Oncol Med"},{"issue":"6","key":"10.1016\/j.clnu.2021.02.011_bib38","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/ibd.21117","article-title":"Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohn's disease","volume":"16","author":"Buchman","year":"2010","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.clnu.2021.02.011_bib39","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/jpen.1011","article-title":"Single-center experience with the use of teduglutide in adult patients with short bowel syndrome","volume":"42","author":"Lam","year":"2018","journal-title":"JPEN - J Parenter Enter Nutr"},{"issue":"5","key":"10.1016\/j.clnu.2021.02.011_bib40","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/ccr3.2127","article-title":"Dose-dependent elevation in amylase and lipase in response to teduglutide administration","volume":"7","author":"Lee","year":"2019","journal-title":"Clin Case Rep"},{"issue":"6","key":"10.1016\/j.clnu.2021.02.011_bib41","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/MCG.0000000000000604","article-title":"Safety and efficacy of teduglutide (Gattex) in patients with Crohn's disease and need for parenteral support due to short bowel syndrome-associated intestinal failure","volume":"51","author":"Kochar","year":"2017","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.clnu.2021.02.011_bib42","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpeds.2016.10.027","article-title":"Outcomes from a 12-week, open-label, multicenter clinical trial of teduglutide in pediatric short bowel syndrome","volume":"181","author":"Carter","year":"2017","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2021.02.011_bib43","article-title":"Clinical characteristics of inflammatory bowel disease patients requiring long-term parenteral support in the present era of highly effective biologic therapy","author":"Kurin","year":"2020","journal-title":"JPEN - J Parenter Enter Nutr"},{"issue":"9","key":"10.1016\/j.clnu.2021.02.011_bib44","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1093\/ibd\/izz087","article-title":"Teduglutide in patients with active Crohn's disease and short bowel syndrome","volume":"25","author":"Al Draiweesh","year":"2019","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"10.1016\/j.clnu.2021.02.011_bib45","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1111\/1440-1681.13361","article-title":"The pivotal relation between glucagon-like peptides, NF\u03baB and inflammatory bowel disease","volume":"47","author":"Azmy Nabeh","year":"2020","journal-title":"Clin Exp Pharmacol Physiol"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561421000856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561421000856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:02:56Z","timestamp":1759366976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561421000856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0261561421000856"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2021.02.011","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Candidacy of adult patients with short bowel syndrome for treatment with glucagon-like peptide-2 analogues: A systematic analysis of a single centre cohort","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2021.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}